Created by potrace 1.16, written by Peter Selinger 2001-2019beatandraise.com
Latest Financials

Filings:

CategoryDateSearch FilingsInstitutional HoldersbetaEarnings TranscriptsbetaGlobal Search

SEC Edgar

Tarsus Pharmaceuticals, Inc.

SIC 2836 · Biological Products, (No Diagnostic Substances)
NotesSupport
aboutterms
$TARS

Tarsus Pharmaceuticals, Inc.

CIK:0001819790|SEC Filings

MATERIAL CONTRACTS

EX-10.2
exhibit102_rra.htm
2026-08-06T00:00:00Z
EX-10.1
exhibit101_spa.htm
2026-08-06T00:00:00Z
EX-10.1
amendmentdatedmay12025to.htm
2025-08-06T00:00:00Z
EX-10.26
yeuelizabeth-offerletter.htm
2025-02-25T00:00:00Z
EX-10.27
tp-03xnovationandtermina.htm
2025-02-25T00:00:00Z
EX-10.25
tarsusnewleaseredacted.htm
2025-02-25T00:00:00Z
EX-10.24
tarsuspharmaceuticalsinc.htm
2025-02-25T00:00:00Z
EX-10.1
pharmakon-tarsusxxloanag.htm
2024-08-08T00:00:00Z
EX-10.1#
josetrevejo-tarsussepara.htm
2024-05-08T00:00:00Z
EX-10.19
exhibit1019-offerletterj.htm
2024-02-27T00:00:00Z
EX-10.1
hercules_tarsus-secondamen.htm
2023-11-09T00:00:00Z
EX-10.2
exhibit102-tarsusformofs.htm
2023-08-10T00:00:00Z
EX-10.1
greensteinleo2023-05x03sep.htm
2023-08-10T00:00:00Z
EX-10.18
tarsuslsafirstamendment1.htm
2023-03-17T00:00:00Z
EX-10.1
elanco-tarsustopicalagre.htm
2022-08-11T00:00:00Z
EX-10.2
elanco-tarsussystemicagr.htm
2022-08-11T00:00:00Z
EX-10.2
exhibit102-consultingagree.htm
2022-05-11T00:00:00Z
EX-10.1
exhibit101-loanandsecurity.htm
2022-05-11T00:00:00Z
EX-10.1
exhibit101lian-tarsusxdeve.htm
2021-05-11T00:00:00Z
EX-10.1
d30607dex101.htm
2020-10-09T00:00:00Z